These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

656 related articles for article (PubMed ID: 28385948)

  • 81. Computational characterization of flow and blood damage potential of the new maglev CH-VAD pump versus the HVAD and HeartMate II pumps.
    Zhang J; Chen Z; Griffith BP; Wu ZJ
    Int J Artif Organs; 2020 Oct; 43(10):653-662. PubMed ID: 32043405
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Progression of aortic valve insufficiency during centrifugal versus axial flow left ventricular assist device support.
    Jimenez Contreras F; Mendiola Pla M; Schroder J; Bryner B; Agarwal R; Russell SD; Mirza J; Daneshmand MA; Milano C
    Eur J Cardiothorac Surg; 2022 May; 61(5):1188-1196. PubMed ID: 35167677
    [TBL] [Abstract][Full Text] [Related]  

  • 83. De Novo Human Leukocyte Antigen Allosensitization in Heartmate 3 Versus Heartmate II Left Ventricular Assist Device Recipients.
    Jain R; Habal MV; Clerkin KJ; Latif F; Restaino SW; Zorn E; Takeda K; Naka Y; Yuzefpolskaya M; Farr MA; Colombo PC; Sayer GT; Uriel N; Topkara VK
    ASAIO J; 2022 Feb; 68(2):226-232. PubMed ID: 33883507
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Use of left ventricular assist device (HeartMate II): a Singapore experience.
    Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
    Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
    [TBL] [Abstract][Full Text] [Related]  

  • 85. European experience of DuraHeart magnetically levitated centrifugal left ventricular assist system.
    Morshuis M; El-Banayosy A; Arusoglu L; Koerfer R; Hetzer R; Wieselthaler G; Pavie A; Nojiri C
    Eur J Cardiothorac Surg; 2009 Jun; 35(6):1020-7; discussion 1027-8. PubMed ID: 19233673
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Present-Day Hospital Readmissions after Left Ventricular Assist Device Implantation: A Large Single-Center Study.
    Hernandez RE; Singh SK; Hoang DT; Ali SW; Elayda MA; Mallidi HR; Frazier OH; Meyers DE
    Tex Heart Inst J; 2015 Oct; 42(5):419-29. PubMed ID: 26504434
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Sildenafil Is Associated With Reduced Device Thrombosis and Ischemic Stroke Despite Low-Level Hemolysis on Heart Mate II Support.
    Saeed O; Rangasamy S; Selevany I; Madan S; Fertel J; Eisenberg R; Aljoudi M; Patel SR; Shin J; Sims DB; Reyes Gil M; Goldstein DJ; Slepian MJ; Billett HH; Jorde UP
    Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29092891
    [TBL] [Abstract][Full Text] [Related]  

  • 88. DuraHeart magnetically levitated centrifugal left ventricular assist system for advanced heart failure patients.
    Morshuis M; Schoenbrodt M; Nojiri C; Roefe D; Schulte-Eistrup S; Boergermann J; Gummert JF; Arusoglu L
    Expert Rev Med Devices; 2010 Mar; 7(2):173-83. PubMed ID: 20214423
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Three-year follow-up after less-invasive left ventricular assist device exchange to HeartMate 3™.
    Hanke JS; Mariani S; Merzah AS; Bounader K; Li T; Haverich A; Schmitto JD; Dogan G
    J Cardiovasc Surg (Torino); 2021 Dec; 62(6):646-651. PubMed ID: 34057162
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Antiplatelet Therapy and Adverse Hematologic Events During Heart Mate II Support.
    Saeed O; Shah A; Kargoli F; Madan S; Levin AP; Patel SR; Jermyn R; Guerrero C; Nguyen J; Sims DB; Shin J; D'Alessandro D; Goldstein DJ; Jorde UP
    Circ Heart Fail; 2016 Jan; 9(1):e002296. PubMed ID: 26721914
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Trends in HeartMate 3: What we know so far.
    Lanfear AT; Hamandi M; Fan J; DiMaio JM; George TJ
    J Card Surg; 2020 Jan; 35(1):180-187. PubMed ID: 31692113
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Pulsatility and flow patterns across macro- and microcirculatory arteries of continuous-flow left ventricular assist device patients.
    Stöhr EJ; Ji R; Mondellini G; Braghieri L; Akiyama K; Castagna F; Pinsino A; Cockcroft JR; Silverman RH; Trocio S; Zatvarska O; Konofagou E; Apostolakis I; Topkara VK; Takayama H; Takeda K; Naka Y; Uriel N; Yuzefpolskaya M; Willey JZ; McDonnell BJ; Colombo PC
    J Heart Lung Transplant; 2023 Sep; 42(9):1223-1232. PubMed ID: 37098374
    [TBL] [Abstract][Full Text] [Related]  

  • 93. A clinical and cost-effectiveness analysis of the HeartMate 3 left ventricular assist device for transplant-ineligible patients: A United Kingdom perspective.
    Lim HS; Shaw S; Carter AW; Jayawardana S; Mossialos E; Mehra MR
    J Heart Lung Transplant; 2022 Feb; 41(2):174-186. PubMed ID: 34922821
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Left Ventricular Assist Device Design Reduces von Willebrand Factor Degradation: A Comparative Study Between the HeartMate II and the EVAHEART Left Ventricular Assist System.
    Bartoli CR; Kang J; Zhang D; Howard J; Acker M; Atluri P; Motomura T
    Ann Thorac Surg; 2017 Apr; 103(4):1239-1244. PubMed ID: 27717422
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Outcomes in HeartMate II Patients With No Antiplatelet Therapy: 2-Year Results From the European TRACE Study.
    Netuka I; Litzler PY; Berchtold-Herz M; Flecher E; Zimpfer D; Damme L; Sundareswaran KS; Farrar DJ; Schmitto JD;
    Ann Thorac Surg; 2017 Apr; 103(4):1262-1268. PubMed ID: 27743637
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Fully magnetically centrifugal left ventricular assist device and long-term outcomes: the ELEVATE registry.
    Schmitto JD; Shaw S; Garbade J; Gustafsson F; Morshuis M; Zimpfer D; Lavee J; Pya Y; Berchtold-Herz M; Wang A; Gazzola C; Potapov E; Saeed D
    Eur Heart J; 2024 Feb; 45(8):613-625. PubMed ID: 38036414
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Expanding the Scope of Multimodality Imaging in Durable Mechanical Circulatory Support.
    Almarzooq ZI; Varshney AS; Vaduganathan M; Pareek M; Stewart GC; Estep JD; Mehra MR
    JACC Cardiovasc Imaging; 2020 Apr; 13(4):1069-1081. PubMed ID: 31542528
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.
    John R; Kamdar F; Liao K; Colvin-Adams M; Miller L; Joyce L; Boyle A
    J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1318-23. PubMed ID: 19026822
    [TBL] [Abstract][Full Text] [Related]  

  • 99. In vitro comparison of the hemocompatibility of two centrifugal left ventricular assist devices.
    Zayat R; Moza A; Grottke O; Grzanna T; Fechter T; Motomura T; Schmidt-Mewes C; Breuer T; Autschbach R; Rossaint R; Goetzenich A; Bleilevens C
    J Thorac Cardiovasc Surg; 2019 Feb; 157(2):591-599.e4. PubMed ID: 30414772
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Recurrent pump thrombosis is common after axial continuous-flow left ventricular assist device exchange.
    Urban M; Um J; Moulton M; Stoller D; Zolty R; Lowes B; Macdonald C; McCain N; Siddique A
    Int J Artif Organs; 2020 Feb; 43(2):109-118. PubMed ID: 31530254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.